{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:07:57Z","timestamp":1786997277891,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.taap.2020.115134","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T21:48:39Z","timestamp":1594676919000},"page":"115134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Pyridoxal isonicotinoyl hydrazone inhibition of FXR is involved in the pathogenesis of isoniazid-induced liver injury"],"prefix":"10.1016","volume":"402","author":[{"given":"Guoqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin\u2019an","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2020.115134_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10517-016-3342-1","article-title":"Complex approach to Xenobiotics hepatotoxicity testing using a microfluidic system","volume":"161","author":"Alexandrova","year":"2016","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.taap.2020.115134_bb0010","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/apt.14678","article-title":"Review article: therapeutic bile acids and the risks for hepatotoxicity","volume":"47","author":"Ashby","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2020.115134_bb0015","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1182\/blood.V91.11.4368","article-title":"Biliary iron excretion in rats following treatment with analogs of pyridoxal isonicotinoyl hydrazone","volume":"91","author":"Blaha","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.taap.2020.115134_bb0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/jgh.12516","article-title":"Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress","volume":"29","author":"Boelsterli","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2020.115134_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/toxsci\/kfy294","article-title":"The isoniazid metabolites hydrazine and Pyridoxal Isonicotinoyl Hydrazone modulate Heme biosynthesis","volume":"168","author":"Brewer","year":"2019","journal-title":"Toxicological sciences\u202f: an official journal of the Society of Toxicology"},{"key":"10.1016\/j.taap.2020.115134_bb0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.510310136","article-title":"Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond","volume":"31","author":"Brunt","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2020.115134_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.1980.tb07147.x","article-title":"Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone","volume":"45","author":"Cikrt","year":"1980","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.taap.2020.115134_bb0040","doi-asserted-by":"crossref","first-page":"114666","DOI":"10.1016\/j.taap.2019.114666","article-title":"Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG(R) cells","volume":"379","author":"Cuykx","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2020.115134_bb0045","doi-asserted-by":"crossref","first-page":"116638","DOI":"10.1016\/j.lfs.2019.116638","article-title":"Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats","volume":"232","author":"Duan","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2020.115134_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000321045","article-title":"Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis referral center","volume":"57","author":"Fahimi","year":"2011","journal-title":"Chemotherapy"},{"key":"10.1016\/j.taap.2020.115134_bb0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfw098","article-title":"Pyrazinamide induced rat Cholestatic liver injury through inhibition of FXR regulatory effect on bile acid synthesis and transport","volume":"152","author":"Guo","year":"2016","journal-title":"Toxicological sciences\u202f: an official journal of the Society of Toxicology"},{"key":"10.1016\/j.taap.2020.115134_bb0060","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/15376516.2015.1033074","article-title":"The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid\/rifampicin-induced hepatotoxicity","volume":"25","author":"Guo","year":"2015","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.taap.2020.115134_bb0065","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/AAC.00854-16","article-title":"Role of inflammatory and oxidative stress, cytochrome P450 2E1, and bile acid disturbance in rat liver injury induced by isoniazid and lipopolysaccharide Cotreatment","volume":"60","author":"Hassan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2020.115134_bb0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tiv.2018.08.001","article-title":"The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity","volume":"53","author":"Kamalian","year":"2018","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.taap.2020.115134_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00063110-200504000-00007","article-title":"Pyridoxine in clinical toxicology: a review","volume":"12","author":"Lheureux","year":"2005","journal-title":"European journal of emergency medicine : official journal of the European Society for Emergency Medicine"},{"key":"10.1016\/j.taap.2020.115134_bb0080","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1124\/dmd.116.070920","article-title":"A high dose of isoniazid disturbs Endobiotic homeostasis in mouse liver","volume":"44","author":"Li","year":"2016","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"10.1016\/j.taap.2020.115134_bb0085","first-page":"10","author":"Liu","year":"2018","journal-title":"Molecular Mechanisms of Apoptosis in HepaRG Cell Line Induced by Polyphyllin VI via the Fas Death Pathway and Mitochondrial-Dependent Pathway. Toxins (Basel)"},{"key":"10.1016\/j.taap.2020.115134_bb0090","first-page":"651","article-title":"Isoniazid induced peripheral neuropathy","volume":"40","author":"Mahashur","year":"1992","journal-title":"J. Assoc. Physicians India"},{"issue":"6","key":"10.1016\/j.taap.2020.115134_bib141","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/clpt.2010.355","article-title":"A fresh look at the mechanism of isoniazid-induced hepatotoxicity","volume":"89","author":"Metushi","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.taap.2020.115134_bib142","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/tx300341r","article-title":"Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats","volume":"25","author":"Metushi","year":"2012","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.taap.2020.115134_bb0095","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/bcp.12885","article-title":"Mechanism of isoniazid-induced hepatotoxicity: then and now","volume":"81","author":"Metushi","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2020.115134_bb0100","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2020.115134_bb0105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1248\/bpb.b18-00028","article-title":"Dysregulation of BSEP and MRP2 may play an important role in isoniazid-induced liver injury via the SIRT1\/FXR pathway in rats and HepG2 cells","volume":"41","author":"Qu","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2020.115134_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1517\/14656566.2014.873404","article-title":"Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis","volume":"15","author":"Silveira","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.taap.2020.115134_bb0115","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.taap.2020.115134_bb0120","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/hep.29888","article-title":"Na(+) -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice","volume":"68","author":"Slijepcevic","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.taap.2020.115134_bb0125","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.xphs.2016.01.013","article-title":"Establishment of a drug-induced, bile acid-dependent hepatotoxicity model using HepaRG cells","volume":"105","author":"Susukida","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.taap.2020.115134_bb0130","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.toxrep.2016.10.004","article-title":"Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients","volume":"3","author":"Toure","year":"2016","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.taap.2020.115134_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats","volume":"185","author":"Verbeke","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2020.115134_bb0140","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1139\/y83-073","article-title":"Isoniazid-induced hepatic steatosis in rabbits: an explanation for susceptibility and its antagonism by pyridoxine hydrochloride","volume":"61","author":"Whitehouse","year":"1983","journal-title":"Can. J. Physiol. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2030260X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2030260X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:51:50Z","timestamp":1758574310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2030260X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S0041008X2030260X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2020.115134","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyridoxal isonicotinoyl hydrazone inhibition of FXR is involved in the pathogenesis of isoniazid-induced liver injury","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2020.115134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115134"}}